These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3727706)

  • 1. High complication and failure rates of anticoagulant therapy are avoidable.
    Broekmans AW; Loeliger EA
    Z Kardiol; 1986; 75 Suppl 2():298-301. PubMed ID: 3727706
    [No Abstract]   [Full Text] [Related]  

  • 2. High complication and failure rates of anticoagulant therapy are unavoidable.
    Nitter-Hauge S; Dale J
    Z Kardiol; 1986; 75 Suppl 2():293-7. PubMed ID: 3727705
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulation is necessary in all patients with mechanical prostheses in sinus rhythm.
    Duveau D
    Z Kardiol; 1986; 75 Suppl 2():326-31. PubMed ID: 3727712
    [No Abstract]   [Full Text] [Related]  

  • 4. Thromboembolic events in prosthetic valve recipients: what is the safe level of anticoagulation?
    Acar J
    J Heart Valve Dis; 1993 Jul; 2(4):395-7. PubMed ID: 8269141
    [No Abstract]   [Full Text] [Related]  

  • 5. Can early thromboembolic complications after valve replacement be avoided?
    Kure HH; Schüller H; Thulin L; Olin C
    Z Kardiol; 1986; 75 Suppl 2():302-4. PubMed ID: 3727707
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of thrombosis in heart valve diseases].
    Meyer BJ; Beer JH
    Ther Umsch; 1998 Dec; 55(12):756-61. PubMed ID: 10025189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation is necessary in patients with atrial fibrillation after mitral valve replacement with bioprostheses.
    Rothlin ME
    Z Kardiol; 1986; 75 Suppl 2():317-20. PubMed ID: 3727710
    [No Abstract]   [Full Text] [Related]  

  • 8. Do all patients with mechanical heart valve prostheses need anticoagulant therapy?
    Dale J; Nitter-Hauge S
    Z Kardiol; 1986; 75 Suppl 2():332-7. PubMed ID: 3727714
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
    Nuñez L; Pinto AG; Larrea JL; Gil Aguado M; Connor FO
    Z Kardiol; 1986; 75 Suppl 2():321-5. PubMed ID: 3727711
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of hemorrhagic and thromboembolic complications in heart valve prosthesis].
    Pospelova EP; Stepanian EP; Shchurkalina TKh; Movsesian RA
    Grudn Khir; 1971; 13(1):49-51. PubMed ID: 5577527
    [No Abstract]   [Full Text] [Related]  

  • 11. Guidelines for prevention of thromboembolic events in valvular heart disease. Ad Hoc Committee of the Working Group on Valvular Heart Disease, European Society of Cardiology.
    Gohlke-Bärwolf C; Acar J; Burckhardt D; Oakley C; Butchart E; Krayenbühl P; Hall R; Bodnar E; Krzeminska-Pakula M; Delahaye JP
    J Heart Valve Dis; 1993 Jul; 2(4):398-410. PubMed ID: 8269142
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anticoagulant treatment of patient with the substitute heart valve].
    Halinen MO; Lassila R
    Duodecim; 2000; 116(2):157-65. PubMed ID: 11764475
    [No Abstract]   [Full Text] [Related]  

  • 13. German experience with low intensity anticoagulation (GELIA): protocol of a multi-center randomized, prospective study with the St. Jude Medical valve.
    Horstkotte D; Bergemann R; Althaus U; Babin-Ebell J; Chares M; Dahm M; Eigel P; Elert O; Emmrich K; Geiger AW
    J Heart Valve Dis; 1993 Jul; 2(4):411-9. PubMed ID: 8269143
    [No Abstract]   [Full Text] [Related]  

  • 14. Long term follow up of 292 patients after valve replacement with the Omnicarbon prosthetic valve.
    Thevenet A; Albat B
    J Heart Valve Dis; 1995 Nov; 4(6):634-9. PubMed ID: 8611979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of thromboembolism following heart valve replacement].
    van de Loo J; Stenzinger W
    Verh Dtsch Ges Inn Med; 1989; 95():275-82. PubMed ID: 2690497
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement. A retrospective, non-randomized study.
    Albertal J; Sutton M; Pereyra D; Segura EV; Aramburu DF; Lardani H; Diaz R
    J Heart Valve Dis; 1993 May; 2(3):302-7. PubMed ID: 8269123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thromboembolic and hemorrhagic complications in valve prosthesis patients].
    Ben Ismail M; Abid F; Abid A; M'Zah N; Chaouche H; Kedidi N
    Ann Cardiol Angeiol (Paris); 1983 Jun; 32(4):237-45. PubMed ID: 6614815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short- and long-term results of triple valve surgery in the modern era.
    Alsoufi B; Rao V; Borger MA; Maganti M; Armstrong S; Feindel CM; Scully HE; David TE
    Ann Thorac Surg; 2006 Jun; 81(6):2172-7; discussion 2177-8. PubMed ID: 16731149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Choice of heart valve prosthesis--1985].
    Borst HG; Frank G; Frimpong-Boateng K; Bednarski P
    Z Kardiol; 1986 Jun; 75(6):311-5. PubMed ID: 3751217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anticoagulant therapy. II. (Possibilities and limits)].
    Fischer M
    Med Welt; 1970 Apr; 14():620-6. PubMed ID: 5445111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.